Background: Occupational therapy (OT) aims at improving performance of daily living tasks, facilitating successful adjustments in lifestyle, and preventing losses of function. Objective: To evaluate ...
Correspondence to Professor Annette van der Helm-van Mil, Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; A.H.M.van_der_Helm{at}lumc.nl Rheumatoid arthritis (RA) is ...
Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, California, USA Correspondence to Dr Michael ...
Department of Internal Medicine/Division Clinical and Experimental Immunology, University Hospital Maastricht, Maastricht, The Netherlands Correspondence to Professor J W C Tervaert, Department of ...
Objectives Osteoarthritis (OA) is the most common degenerative joint disease in aged population and its development is significantly influenced by aberrant epigenetic modifications of numerous OA ...
1 Paris-Descartes University, Rheumatology A Department, Cochin Hospital, AP-HP, Paris, France 2 Paris-Descartes University, Radiology A Department, Cochin Hospital, AP-HP, Paris, France 3 ...
Correspondence to Dr Tristan Maerz, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA; tmaerz{at}med.umich.edu Objectives Synovium is acutely affected following joint ...
Correspondence to Dr Elizabeth V Arkema, Clinical Epidemiology Unit, T2, Karolinska Institutet, Stockholm 17176, Sweden; Elizabeth.Arkema{at}ki.se Objective To estimate the risk of tuberculosis (TB) ...
Objectives Knee osteoarthritis (KOA) is a leading cause of global disability with conventional exercise yielding only modest improvements. Here we aimed to investigate the benefits of integrating ...
Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...
Objectives To analyse the new evidence (2018–2022) for the management of systemic lupus erythematosus (SLE) to inform the 2023 update of the European League Against Rheumatism (EULAR) recommendations.